Background: We conducted a trial to evaluate the efficacy and safety of apatinib, a tyrosine inhibitor against vascular endothelial growth factor receptor 2, combined with neoadjuvant chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC).

中文翻译：

---

阿帕替尼联合紫杉醇顺铂新辅助化疗治疗局部晚期食管鳞状细胞癌

背景：我们进行了一项试验，以评估阿帕替尼（一种针对血管内皮生长因子受体 2 的酪氨酸抑制剂）联合新辅助化疗对局部晚期食管鳞状细胞癌 (ESCC) 患者的疗效和安全性。